Hypocaloric diet and pharmacological treatment reduces body weight, insulin resistance and androgen levels and restore menstruation in obese women with polycystic ovary syndrome
Journal Title: Postępy Nauk Medycznych - Year 2010, Vol 23, Issue 8
Abstract
Objective. To estimate the effects of the hypocaloric diet and pharmacological treatment with sibutramine on body weight, fat mass, especially abdominal fat, insulin resistance, serum androgens and menstruation pattern in overweight and obese women with polycystic ovary syndrome.Material and methods. 20 females with PCOS aged 19 – 49 years with BMI 27,3-53,8 kg/m2 studied before and after 1,3 and 6 months of the treatment with hypocaloric diet and sibutramine 10-15 mg/day. Measurement included body weight, BMI, waist circumference, total and trunk fat mass, glucose, insulin, blood lipids, androgens, LH,FSH, estradiol, fT4, TSH and menstrual pattern.Results. Body weight, BMI and waist circumference significantly decreased already after 1st month (p<0,001) and were decreasing further during next months. Fat mass decreased of 9,2% (p<0,001) and fat mass of the trunk of 8,2% (p<0,001) after 6 months. In the same time significant decrease in serum fasting glucose (p<0,01), insulin (p<0,01), total cholesterol (p<0,01), LDL-cholesterol (p<0,05) and triglicerydes (p<0,01) were observed. HDL-cholesterol increased significantly (p<0,001). Throughout the study serum testosterone, androstendione and DHEA-S levels decreased significantly (p<0,01; p<0,05 and p<0,001, respectively). Menstrual bleedings reoccurred in eighteen women throughout the study.Conclusions. Hypocaloric diet plus pharmacological treatment with sibutramine caused a significant weight loss, had beneficial effects on some metabolic and cardiovascular risk factors, reduced androgens and restored menstruations in overweight and obese women with polycystic ovary syndrome.
Authors and Affiliations
Jarosław Kozakowski , Wojciech Zgliczyński
Keywords
Related Articles
- EP ID EP53941
- DOI -
- Views 158
- Downloads 0
Ω-3 PUFA supplementation decreases nuclear factor κB activity and attenuates pressure overload-induced cardiac dysfunction
Introduction. Supplementation with ω-3 polyunsaturated fatty acids (ω-3 PUFA) exerts cardioprotective effects in heart failure patients, however the mechanism is not well know. The present study assessed the effect of DH...
New medicines and theirs adverse events in therapy of chronic HCV infection
On beginning of years 90, recombined interferon use in therapy of patients with chronic HCV infection was effective at about 15%. Associating of this therapy from rybavirin, and then replacement recombined interferon by...
Wybór postępowania w tętniakach tętnic podkolanowych
Tętniaki tętnic podkolanowych cały czas stanowią problem diagnostyczny i terapeutyczny. Autorzy przeanalizowali piśmiennictwo od 2000 roku oraz 24 przypadki leczonych w Klinice Chirurgii Naczyniowej i Angiologii CMKP, tę...
Skuteczność kinesiotapingu w leczeniu urazów tkanek miękkich u młodych sportowców
<b>Cel pracy. </b>Celem pracy była ocena skuteczności kinesiotapingu w leczeniu urazów tkanek miękkich u młodych zawodników piłki nożnej.<br><b>Materiał i metody.&a...
Magnesaemia in dialysis patients – the unappreciated feature of mineral metabolism
Magnesium plasma concentration are seldom controlled in dialysis patients. This articleaddresses the role of magnesium as the fourth most abundant cation, the consequencesof hypo- and hypermagnesaemia, and the prevalence...